Sichuan Wanma Benteng Technology Co. (NASDAQ:WMBT) submitted its S-1 filing this afternoon for a $70 million IPO and intends to focus its search in the China and Asia-Pacific areas.
However, the new SPAC submitted the filing without any expertise attached, becoming the third company to do so this year. This means that the filing was made without the guidance of underwriters, legal counsel, or auditors to provide advice on the process.
This trend was initiated by GRD Biotechnology (NASDAQ:CGRD) when it submitted a $40 million IPO filing back in July, followed by Lianfeng’s(NASDAQ:LFKJ) $70 million IPO filing in October.
Notably, all three SPACs have a focus on China and maintain identical terms with a 24-month timeline, absence of warrants or rights, and a fully funded trust of 100%.
Sichuan Wanma Benteng Tech is led by CEO and Chairman Mr. Xinchun Wu, who has more than three decades of experience in export trade and new energy. The S-1 did not divulge further details on Mr. Wu’s prior work history, but noted that as of last year, he was the Chairman of Yundu Huisheng Technology Co.
Mr. Wu is joined by CFO Mr. Bin Yu, who is also one of the founders of Yunchuang Blueprint (Xiamen) Technology Group Co. Mr. Yu has served as deputy general manager at an undisclosed accelerator company in China and as an operations manager at a Hong Kong-listed company.
SPAC TERMS
Vendome Acquisition Corporation I (NASDAQ:VNMEU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “VNMEU”, Wednesday, July 2, 2025. The new SPAC plans to focus its search on target business in the consumer sector operating in North America, Southeast Asia, and Europe....
Origin Investment Corp. I (NASDAQ:ORIQU) announced the pricing of its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ORIQU”, Wednesday, July 2, 2025. The new SPAC aims to mount a broad search for a target with a strong management and both revenue and earnings growth potential....
1RT Acquisition Corp. (NASDAQ:ONCHU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ONCHU”, Wednesday, July 2, 2025. The new SPAC plans to target company in the digital asset ecosystem involved in the creation, storage, exchange or management of such assets, whether...
D. Boral ARC Acquisition II Corp. (NASDAQ:ARBCU) has filed for a $250 million SPAC to give underwriter D. Boral a second in-house SPAC to pursue deals with. The new SPAC offers investors a 1/2 warrant and an initial 18-month time frame to complete a deal. D. Boral II’s sponsor may automatically extend this once by...
Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...